Financial News
Press Releases about Pfizer
![](https://mms.businesswire.com/media/20231012073213/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20231011089993/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://pressreach.com/wp-content/uploads/2023/10/Angellodeco.jpg)
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
October 10, 2023
Via PressReach
![](https://pressreach.com/wp-content/uploads/2023/10/image1-3.jpg)
Big Pharma’s Billion-Dollar Bets on Advanced Cancer Therapies
October 10, 2023
Via PressReach
Exposures
COVID-19
![](https://mms.businesswire.com/media/20231005029636/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20231003690582/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230928191953_5-stocks-that-have-massive-upside-according-to-ana.jpg)
![](https://s3-us-west-2.amazonaws.com/issuewireassets/primg/119818/mid_photo-2023-08-19-11-26-04-2473474132.jpg)
Kevin Dodelande's iMi launches into early cancer detection
September 28, 2023
Via IssueWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://mms.businesswire.com/media/20230922409879/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230919053331_flee-to-healthcare-stocks-if-recession-rears-its-h.jpg)
![](https://mms.businesswire.com/media/20230919023508/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20230918672148/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20230918178824/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Invites Public to View and Listen to Webcast of October 31 Conference Call with Analysts
September 18, 2023
From Pfizer Inc.
Via Business Wire
![](https://www.marketbeat.com/logos/articles/med_20230918072814_can-these-3-healthcare-dividend-stocks-deliver-inc.jpg)
![](https://mms.businesswire.com/media/20230912226526/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20230907854671/en/1670922/22/pfizer-biontech-logos.jpg)
Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 COVID-19 Vaccine
September 11, 2023
From Pfizer Inc.
Via Business Wire
![](https://www.newmediawire.com/media/sites/270/images/social-image.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230906193116_3-stocks-to-buy-for-the-covid-resurgence.jpg)
![](https://mms.businesswire.com/media/20230905113646/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20230829323192/en/1878095/22/BioNTech_Logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.